A Study to Evaluate the Safety and Efficacy of ALMB-0168 in Patients With Osteosarcoma

Condition:   Osteosarcoma Intervention:   Drug: ALMB-0168 Sponsors:   AlaMab Therapeutics (Shanghai) Inc.;   CSPC ZhongQi Pharmaceutical Technology Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials